Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

1.8%

Category Returns

7.96%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) 0.34 0.43 1.80 2.82 2.11 21.53 14.91 13.06 19.63
Equity - Sectoral Fund - Pharma & Health Care 0.23 2.55 7.96 4.27 4.83 21.15 17.73 19.04 16.54

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    505.9512

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    301, Centrium, 3rd Floor, 57, L.B.S. Road Nav Pada, Kurla (West) Mumbai - 400070

  • Phone

    022 - 4617 0911

  • Fax

  • Email

    investorsupport.mfs@kfintech.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 99.46
Others : 0.54

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 109936.56 13.92
Lupin Limited 66732.67 8.45
Divi's Laboratories Limited 50594.34 6.41
Dr. Reddy's Laboratories Limited 47055.56 5.96
Cipla Limited 42786.45 5.42
Apollo Hospitals Enterprise Limited 40715.1 5.15
MedPlus Health Services Limited 30465.5 3.86
Ajanta Pharma Limited 26545.31 3.36
Max Healthcare Institute Limited 25578.72 3.24
Vijaya Diagnostic Centre Limited 24865.9 3.15
Sai Life Sciences Limited 24841.84 3.15
Mankind Pharma Limited 22689.51 2.87
Aurobindo Pharma Limited 22209.11 2.81
IPCA Laboratories Limited 21852.25 2.77
GlaxoSmithKline Pharmaceuticals Limited 20848.95 2.64
Abbott India Limited 19225.56 2.43
Alkem Laboratories Limited 17151.7 2.17
JB Chemicals & Pharmaceuticals Limited 16507.95 2.09
Dr. Lal Path Labs Limited 15984.32 2.02
Thyrocare Technologies Limited 15352.66 1.94
Pfizer Limited 15022.94 1.9
Gland Pharma Limited 13578.11 1.72
Narayana Hrudayalaya Limited 13226.24 1.67
Emcure Pharmaceuticals Limited 11907.81 1.51
Sanofi Consumer Healthcare India Limited 9183.49 1.16
Suraksha Diagnostic Limited 8881.73 1.12
Fortis Healthcare Limited 8775.92 1.11
Sanofi India Limited 7391.04 0.94
Syngene International Limited 7343.27 0.93
Akums Drugs and Pharmaceuticals Limited 7062.65 0.89
Anthem Biosciences Limited 6946.43 0.88
Triparty Repo 6802.4 0.86
Biocon Limited 5302.97 0.67
AstraZeneca Pharma India Limited 4858.72 0.62
Indoco Remedies Limited 3009.28 0.38
Concord Biotech Limited 1137.94 0.14
Cash Margin - CCIL 42.83 0.01
Net Current Assets -2589.56 -0.33

Sectors - Holding Percentage

Sector hold percentage
Healthcare 94.67%
Retailing 3.86%
Business Services 0.93%
Miscellaneous 0.86%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
HDFC Pharma and Healthcare Fund - Growth Option 506.59 5.28 7.72 2.9 11.23 0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 102.69 2.06 5.35 -2.28 7.66 0
Mirae Asset Healthcare Fund -Regular Growth 1583.14 2.63 6.62 -0.13 6.64 23.24
quant Healthcare Fund - Growth Option - Regular Plan 137.36 7.55 8.23 -0.58 6.39 0
Kotak Healthcare Fund - Regular Plan - Growth Option 214.38 2.96 7.73 -0.66 6.17 0
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 4.2 5.07 -2.82 5.51 24.1
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 3.92 1.82 -4.7 4.37 25.91
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 453.42 1.8 3.99 -1.15 3.95 22.41
PGIM India Healthcare Fund - Regular Plan - Growth Option 109.73 2.68 5.62 -1.48 3.64 0
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH 292.24 5.04 4.15 -3.06 3.3 0

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 68969.15 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 68571.85 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 68287.15 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 67641.5 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 66601.8 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 66136.11 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 65922 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 65812.16 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 64821.04 12.17 8.42 0.27 7.92 21.91
Nippon India Small Cap Fund - Growth Plan - Growth Option 63006.73 12.17 8.42 0.27 7.92 21.91